Literature DB >> 32345521

Re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.

Peng He1, Xiaohui Wang2, Hao Li3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32345521      PMCID: PMC7177112          DOI: 10.1016/j.eururo.2020.04.041

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
We read the article by Xiao et al [1] on chronic kidney disease (CKD) patients during the coronavirus disease 2019 (COVID-19) pandemic. Clinical research and autopsies have revealed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is common among individuals with conditions that include renal failure, diabetes, Parkinson’s disease, and physical and mental disabilities [2]. In 2003, an outbreak of SARS occurred among residents of Amoy Gardens, Hong Kong SAR, China. It had been speculated that a patient with renal failure might have carried an extraordinarily high viral load because of immunosuppression, which might then have been transmitted via aerosol formation through the sewers and could have led to a large outbreak [3]. This small case series served as a cautionary tale, highlighting that close attention to SARS-CoV-2 infection in CKD patients is warranted. As reported by the authors, patients with CKD may be more susceptible to SARS-CoV-2 infection compared to the general normal population [1]. In patients with CKD, impairment of the immune system could result in greater susceptibility to bacterial and viral infections. Moreover, these patients need routine hemodialysis (HD) in hospital two to three times per week. Some symptoms in HD patients with COVID-19 may be difficult to distinguish from other symptoms common in the HD population. Our hospital is one of the designated hospitals for patients with COVID-19 in Wuhan, China. To add to the report by Xiao et al [1], we noted in our HD center dozens of new patients with end-stage renal disease undergoing HD, and more than 20% tested positive for SARS-CoV-2 from February to March 2020. Moreover, several patients did not seem to present with obvious respiratory symptoms before dyspnea, but their condition deteriorated rapidly after dyspnea occurred. Another HD center in Wuhan reported that 37/230 HD patients (16.09%) and four/33 medical staff (12.12%) were diagnosed with COVID-19, most with mild symptoms [4], suggesting that HD patients have higher susceptibility to SARS-CoV-2 infection and HD centers are high-risk areas during the COVID-19 pandemic. In addition, researchers in Italy published recommendations for HD patients and HD centers during the pandemic [5], suggesting that HD patients should maximize social distancing, efforts should focus on early detection of infected cases, and the need for hospitalization should be minimized. They also provided recommendations for the safety of medical staff in HD centers. In summary, HD patients are susceptible to SARS-CoV-2 with mild or no symptoms. Medical staff should take preventive measures to detect patients with COVID-19 as early as possible with the aim of reducing the probability of infection of health care providers and other patients. The authors have nothing to disclose. We are grateful for grant B2014070 from the Scientific Research Project of Hubei Education Department.
  3 in total

1.  Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection.

Authors:  Yu Xiao; Kaiyu Qian; Yongwen Luo; Song Chen; Mengxin Lu; Gang Wang; Lingao Ju; Xinghuan Wang
Journal:  Eur Urol       Date:  2020-04-10       Impact factor: 20.096

2.  Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic.

Authors:  Bjorn Meijers; Piergiorgio Messa; Claudio Ronco
Journal:  Blood Purif       Date:  2020-04-01       Impact factor: 2.614

3.  Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients.

Authors:  Ping-Nam Wong; Siu-Ka Mak; Kin-Yee Lo; Gensy M W Tong; Yuk Wong; Chi-Leung Watt; Andrew K M Wong
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.